SMTL ID : 7dxl.2 (1 other biounit)

Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 3.15 Å

Oligo State

monomer

Ligands

1 x E56: 3-[4-[6-chloranyl-5-[[(3R)-pyrrolidin-3-yl]amino]-1H-indazol-3-yl]pyrazol-1-yl]benzenecarbonitrile(Non-covalent)

E56.1: 15 residues within 4Å: Chain A: L.25, V.33, A.49, K.51, M.82, L.103, P.104, F.105, M.106, K.107, R.159, N.160, M.162, A.172, D.173 6 PLIP interactions: 6 interactions with chain A Hydrophobic interactions: A:L.25, A:V.33, A:A.49 Hydrogen bonds: A:P.104, A:M.106, A:D.173

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Ng, P.S. et al., Fragment-based lead discovery of indazole-based compounds as AXL kinase inhibitors. Bioorg.Med.Chem. (2021)

Release Date

2021-10-13

Peptides

Tyrosine-protein kinase Mer: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
B

Tyrosine-protein kinase Mer

Related Entries With Identical Sequence